You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Digestive Dysmotility in Mitochondrial Neurogastrointestinal

Recruiting
  • MNGIE
  • Dysmotility
    • Barcelona, Spain
      Hospital Universitari Vall d'Hebron
    Dec 17, 2022

    Mitochondrial Diseases, Mitochondrial Encephalomyopathy, Mitochondrial Encephalopathy Trial in Montréal (deoxycytidine and

    Recruiting
    • Mitochondrial Diseases
    • +4 more
    • deoxycytidine and deoxythymidine
    • Montréal, Quebec, Canada
      Research InstituMcGill University Health Centre - Children Hospi
    Jan 26, 2023

    Natural History Study of MNGIE

    Suspended
    • Mitochondrial Neurogastrointestinal Encephalomyopathy
    • Non-interventional
    • Aurora, Colorado
    • +4 more
    Jul 16, 2021

    Tissue Sample Study for Mitochondrial Disorders

    Enrolling by invitation
    • Mitochondrial Disorders
    • +8 more
      • New York, New York
        Columbia University
      Apr 4, 2022

      MELAS Syndrome Trial in Madrid (Glutamine oral supplementation)

      Completed
      • MELAS Syndrome
      • Glutamine oral supplementation
      • Madrid, Spain
        Hospital Universitario 12 de Octubre
      Feb 8, 2022

      Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD Trial in Austria, Germany, Italy

      Recruiting
      • Mitochondrial Diseases
      • +17 more
        • Innsbruck, Austria
        • +18 more
        Sep 23, 2022

        Leigh Syndrome, Leigh Disease, Leigh's Necrotizing Encephalopathy Trial in Houston

        Recruiting
        • Leigh Syndrome
        • +4 more
          • Houston, Texas
            The University of Texas Health Science Center at Houston
          May 16, 2022

          MELAS Syndrome Trial in Madrid (Glutamine oral supplement)

          Active, not recruiting
          • MELAS Syndrome
          • Glutamine oral supplement
          • Madrid, Spain
            Hospital Universitario 12 de Octubre
          Feb 24, 2022

          Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Stem Cell Transplantation, IMD

          Recruiting
          • Mucopolysaccharidosis Disorders
          • +28 more
          • Stem Cell Transplantation
          • +7 more
          • Minneapolis, Minnesota
            Masonic Cancer Center, University of Minnesota
          Nov 1, 2022

          Mitochondrial Diseases, Metabolic Disease, Inborn Errors of Metabolism Trial (EE-TP)

          Not yet recruiting
          • Mitochondrial Diseases
          • +2 more
          • EE-TP
          • (no location specified)
          Nov 4, 2019

          Primary Mitochondrial Disease Trial in Germany, Italy (OMT-28)

          Recruiting
          • Primary Mitochondrial Disease
          • Bonn, Germany
          • +5 more
          Aug 3, 2023

          Sepsis Associated Encephalopathy (SAE) Biomarkers

          Recruiting
          • Sepsis
          • +4 more
          • Blood draws
          • Gainesville, Florida
            University of Florida
          Oct 27, 2022

          Samples of Bone Marrow Aspiration From Myelodysplastic Syndrome

          Recruiting
          • Myelodysplastic Syndromes
          • Blood test
          • Jerusalem, Israel
            Shaare Zedek Medical Center
          Nov 27, 2023

          Dravet Syndrome, Lennox Gastaut Syndrome, Epileptic Encephalopathy Trial in Worldwide (ZX008 (Fenfluramine Hydrochloride))

          Active, not recruiting
          • Dravet Syndrome
          • +2 more
          • ZX008 (Fenfluramine Hydrochloride)
          • Tucson, Arizona
          • +86 more
          Jan 5, 2023

          Mitochondrial Diseases, Pearson Syndrome Trial in Ramat Gan (MNV-201)

          Recruiting
          • Mitochondrial Diseases
          • Pearson Syndrome
          • MNV-201
          • Ramat Gan, Israel
            Sheba Medical Center
          Aug 24, 2023

          Mitochondrial DNA Depletion Syndrome 2 Myopathic Type, Thymidine Kinase 2 Deficiency Trial in New York (Thymidine)

          Active, not recruiting
          • Mitochondrial DNA Depletion Syndrome 2 Myopathic Type
          • Thymidine Kinase 2 Deficiency
          • New York, New York
            Columbia University Irving Medical Center
          Jul 28, 2022

          Acute on Chronic Liver Failure in Cirrhotic Patients at Assiut

          Not yet recruiting
          • Acute-On-Chronic Liver Failure
          • laboratory tests
          • (no location specified)
          Nov 18, 2023

          MELAS Syndrome Trial in Houston (L-Citrulline)

          Recruiting
          • MELAS Syndrome
          • Houston, Texas
            Baylor St. Luke'S Medical Center
          Apr 15, 2022

          SCN8A Developmental and Epileptic Encephalopathy Syndrome Trial in Fort Worth (NBI-921352)

          Enrolling by invitation
          • SCN8A Developmental and Epileptic Encephalopathy Syndrome
          • San Francisco, California
          • +2 more
          Nov 23, 2022

          SCN8A Developmental and Epileptic Encephalopathy Syndrome Trial in United States (NBI-921352, Placebo)

          Recruiting
          • SCN8A Developmental and Epileptic Encephalopathy Syndrome
          • San Francisco, California
          • +8 more
          Nov 23, 2022

          Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia, Neonatal Encephalopathy Trial in India (Normal Saline along with standard

          Not yet recruiting
          • Hypoxic-Ischemic Encephalopathy
          • +2 more
          • Normal Saline along with standard treatment
          • Sovateltide along with standard treatment
          • Belgaum, Karnataka, India
          • +3 more
          Aug 22, 2022

          Inflammatory Biomarkers for the Diagnosis of oPRES

          Completed
          • Posterior Reversible Encephalopathy Syndrome
          • +2 more
          • Whether the PE or E patient combined with PRES
          • Guangzhou, China
            Department of Obstetrics and Gynecology, Key Laboratory for Majo
          Aug 2, 2022

          The Predictors of ICU Admission of oPRES

          Completed
          • Posterior Reversible Encephalopathy Syndrome
          • Intensive Care Units
          • Whether the patient needs to be admitted to the ICU
          • Guangzhou, China
            Department of Obstetrics and Gynecology, Key Laboratory for Majo
          Jun 11, 2022

          Mitochondrial DNA Copy Number and Leukocyte Telomere Length as

          Recruiting
          • Type 2 Diabetes Mellitus
          • Genotyping
          • Sohag, Egypt
            Sohag Univversity
          Jan 12, 2023

          Mitochondrial Dysfunction in Primary Progressive Multiple

          Recruiting
          • Multiple Sclerosis
            • Milan, MI, Italy
            • +1 more
            Aug 29, 2023